ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.68B
Enterprise Value 31.43B
Trailing P/E 49.97
Forward P/E 1
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)12.85
Price/Book (mrq)5.28
Enterprise Value/Revenue 310.94
Enterprise Value/EBITDA 629.59

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 26.35%
Operating Margin (ttm)35.28%

Management Effectiveness

Return on Assets (ttm)9.30%
Return on Equity (ttm)11.72%

Income Statement

Revenue (ttm)130.51M
Revenue Per Share (ttm)6.84
Quarterly Revenue Growth (yoy)265.80%
Gross Profit (ttm)102.81M
EBITDA 48.27M
Net Income Avi to Common (ttm)34.38M
Diluted EPS (ttm)1.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)220.44M
Total Cash Per Share (mrq)11.51
Total Debt (mrq)1.89M
Total Debt/Equity (mrq)0.59
Current Ratio (mrq)12.88
Book Value Per Share (mrq)16.58

Cash Flow Statement

Operating Cash Flow (ttm)53.92M
Levered Free Cash Flow (ttm)43.24M

Trading Information

Stock Price History

Beta 1.49
52-Week Change 3178.05%
S&P500 52-Week Change 313.44%
52 Week High 395.91
52 Week Low 329.46
50-Day Moving Average 383.99
200-Day Moving Average 365.76

Share Statistics

Avg Vol (3 month) 3219.09k
Avg Vol (10 day) 3113.78k
Shares Outstanding 519.16M
Float 14.49M
% Held by Insiders 124.92%
% Held by Institutions 175.45%
Shares Short 3816.68k
Short Ratio 35.17
Short % of Float 35.10%
Shares Short (prior month) 3913.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A